准确识别和分享COVID-19错误信息是否与年龄较大和神经认知功能较低有关?
Anastasia Matchanova1, Steven Paul Woods1, Clayton Neighbors1
1Department of Psychology, University of Houston, 3695 Cullen Blvd, 126 Heyne Bldg (Ste. 239d), Houston, TX 77004 USA.
Current psychology (New Brunswick, N.J.)
|June 26, 2023
概括
老年人和年轻人不同地分享COVID-19错误信息,像口头智商和计算能力这样的认知技能会影响分享的可能性. 标题准确性判断对于这两个年龄组都是关键的.
科学领域:
- 认知心理学 认知心理学
- 卫生沟通健康沟通
- 社会媒体研究 社交媒体研究
背景情况:
- 在线传播COVID-19错误信息的广泛传播导致了严重的负面健康和社会结果.
- 了解影响不同年龄组识别和共享错误信息的因素对于公共卫生至关重要.
- 认知能力和健康素养的个体差异可能在易受错误信息的影响中起作用.
研究的目的:
- 调查与年龄相关的差异,以辨别COVID-19头条新闻的准确性.
- 检查COVID-19错误信息在线共享的年龄相关差异.
- 探索全球认知,健康素养和口头智商对错误信息共享的影响.
主要方法:
- 一项涉及52名年轻成年人 (18-35岁) 和50名老年人 (50岁以上) 的研究.
- 参与者通过电话完成了神经认知评估,健康素养和数学的测量.
- 一个社交媒体头条分享实验呈现真假的COVID-19头条,以衡量分享的可能性和感知的准确性.
主要成果:
- 在标题准确性辨别或错误信息共享方面没有发现显著的年龄影响.
- 一个显著的互动表明,标题准确性与分享虚假标题 (r = - - 64) 比分享真实标题 (r = - - 43) 有更强的关系.
- 较低的口头智商和计算能力与老年人更高的虚假头条分享有关;年轻的成年人与较低的口头智商,计算能力和全球认知有类似的关联.
结论:
- 标题准确性判断,计算能力和口头智商是共享COVID-19错误信息的重要因素,无论是老年人还是年轻人.
- 认知能力,而不仅仅是年龄,在导航在线健康信息方面似乎至关重要.
- 未来的干预措施可以集中在心理教育上,以提高健康和科学素养,特别是关于在线信息.
相关概念视频
Cognitive Development During Adulthood
160
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
160
Alzheimer's Disease: Overview
530
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
530
Dementia
142
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
142
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
163
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
163
Role of Neurotransmitters in Memory
668
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
668
Negative and Cognitive Symptoms of Schizophrenia
97
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
97


